rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2004-12-7
|
pubmed:abstractText |
Data from animal models of fibrosis and fatty liver suggest that leptin may mediate the profibrogenic responses in the liver, but the association of leptin and liver fibrosis in human nonalcoholic fatty liver disease (NAFLD) remains undefined. We aimed at determining the relation between leptin and liver fibrosis in human NAFLD.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0168-8278
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
41
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
943-9
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:15582127-Adult,
pubmed-meshheading:15582127-Aged,
pubmed-meshheading:15582127-Aging,
pubmed-meshheading:15582127-Case-Control Studies,
pubmed-meshheading:15582127-Disease Progression,
pubmed-meshheading:15582127-Fatty Liver,
pubmed-meshheading:15582127-Female,
pubmed-meshheading:15582127-Humans,
pubmed-meshheading:15582127-Insulin Resistance,
pubmed-meshheading:15582127-Leptin,
pubmed-meshheading:15582127-Liver,
pubmed-meshheading:15582127-Liver Cirrhosis,
pubmed-meshheading:15582127-Male,
pubmed-meshheading:15582127-Middle Aged
|
pubmed:year |
2004
|
pubmed:articleTitle |
Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease.
|
pubmed:affiliation |
Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55095, USA. angulohernandez.paul@mayo.edu
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|